Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 837

1.

Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model.

Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, Hwang DY, Cho JY.

Int J Mol Med. 2008 Oct;22(4):529-39.

PMID:
18813861
2.
3.

Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw.

Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY, Kim YK.

Exp Neurol. 2004 Mar;186(1):20-32.

PMID:
14980807
4.

Early changes in behavior deficits, amyloid beta-42 deposits and MAPK activation in doubly transgenic mice co-expressing NSE-controlled human mutant PS2 and APPsw.

Hwang DY, Cho JS, Oh JH, Shim SB, Jee SW, Lee SH, Seo SJ, Song CW, Lee SH, Kim YK.

Cell Mol Neurobiol. 2005 Aug;25(5):881-98.

PMID:
16133940
5.

Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

Hoshino T, Murao N, Namba T, Takehara M, Adachi H, Katsuno M, Sobue G, Matsushima T, Suzuki T, Mizushima T.

J Neurosci. 2011 Apr 6;31(14):5225-34. doi: 10.1523/JNEUROSCI.5478-10.2011.

6.

Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease.

Um HS, Kang EB, Koo JH, Kim HT, Jin-Lee, Kim EJ, Yang CH, An GY, Cho IH, Cho JY.

Neurosci Res. 2011 Feb;69(2):161-73. doi: 10.1016/j.neures.2010.10.004. Epub 2010 Oct 20.

PMID:
20969897
7.

Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.

Feng Z, Qin C, Chang Y, Zhang JT.

Free Radic Biol Med. 2006 Jan 1;40(1):101-9. Epub 2005 Sep 7.

PMID:
16337883
8.

Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease.

Hwang DY, Chae KR, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lee MR, Lim HJ, Min SH, Cho JY, Hong JT, Song CW, Paik SG, Cho JS, Kim YK.

FASEB J. 2002 Jun;16(8):805-13.

9.

Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, Connor J.

J Neurosci Res. 2003 Jan 1;71(1):46-63.

PMID:
12478613
10.

Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).

Crawford FC, Wood M, Ferguson S, Mathura VS, Faza B, Wilson S, Fan T, O'Steen B, Ait-Ghezala G, Hayes R, Mullan MJ.

Brain Res. 2007 Dec 14;1185:45-58. Epub 2007 Sep 25.

PMID:
17961517
11.

Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.

Abrahamson EE, Ikonomovic MD, Ciallella JR, Hope CE, Paljug WR, Isanski BA, Flood DG, Clark RS, DeKosky ST.

Exp Neurol. 2006 Feb;197(2):437-50. Epub 2005 Nov 21.

PMID:
16300758
12.

Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice.

Gan L, Qiao S, Lan X, Chi L, Luo C, Lien L, Yan Liu Q, Liu R.

Neurobiol Dis. 2008 Jan;29(1):71-80. Epub 2007 Aug 21.

13.

Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.

Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L, Aisen PS, Pasinetti GM.

Neurobiol Aging. 2002 May-Jun;23(3):327-34.

PMID:
11959394
14.

Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease.

Richardson JC, Kendal CE, Anderson R, Priest F, Gower E, Soden P, Gray R, Topps S, Howlett DR, Lavender D, Clarke NJ, Barnes JC, Haworth R, Stewart MG, Rupniak HT.

Neuroscience. 2003;122(1):213-28.

PMID:
14596862
15.

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.

Burbach GJ, Hellweg R, Haas CA, Del Turco D, Deicke U, Abramowski D, Jucker M, Staufenbiel M, Deller T.

J Neurosci. 2004 Mar 10;24(10):2421-30.

16.

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA.

Amino Acids. 2003 Dec;25(3-4):437-44. Epub 2003 Nov 7. Review.

PMID:
14661103
17.

Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.

Leem YH, Lim HJ, Shim SB, Cho JY, Kim BS, Han PL.

J Neurosci Res. 2009 Aug 15;87(11):2561-70. doi: 10.1002/jnr.22075.

PMID:
19360903
18.

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME.

Ann Neurol. 2001 Oct;50(4):468-75.

PMID:
11601499
19.

Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease.

Supnet C, Noonan C, Richard K, Bradley J, Mayne M.

J Neurochem. 2010 Jan;112(2):356-65. doi: 10.1111/j.1471-4159.2009.06487.x. Epub 2009 Nov 7.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk